As India began vaccinating children of 12 to 14 age group from Wednesday morning, Prime Minister Narendra Modi tweeted, "Today is an important day in India's efforts to vaccinate our citizens. Now onwards, youngsters in the 12-14 age group are eligible for vaccines and all those above 60 are eligible for precaution doses. I urge people in these age groups to get vaccinated".
The daily positivity rate was at 0.17 per cent and 12 children were among the newly infected people, it said, adding that 46,795 samples were tested in the past 24 hours.
The state now has 822 active cases, while 12,76,782 people have recovered from the disease so far, including 107 in the last 24 hours.
The second worst hit country in terms of cases is India (42,993,494 infections and 515,877 deaths), followed by Brazil (29,391,345 infections and 655,557 deaths).
The number of people who have recuperated from the disease surged to 4,24,46,171 and the case fatality rate was recorded as 1.20 per cent.
The counsel appearing for the UPSC told the apex court that he needs to take instructions and place on record all the aspects before any decision is taken on the issue.
The active COVID-19 cases in the country has dipped to 54,118 and comprised 0.13 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.68 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,962,953 infections and 515,036 deaths), followed by Brazil (29,056,525 infections and 652,438 deaths).
The Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for conducting a phase-3 clinical trial of the single-dose COVID-19 vaccine Sputnik Light as a booster dose.
The country has also administered over 2 crore precaution doses among the eligible beneficiaries. Additionally, over 97 per cent of India's adult population has also received their first dose of vaccine against Covid-19.
In a research note, India Ratings and Research (Ind-Ra) said it has maintained a neutral outlook for the Indian pharmaceutical sector for FY23.
The active cases comprise 0.17 per cent of the total infections, while the national COVID-19 recovery rate has further improved to 98.65 per cent, the ministry said.
The second worst hit country in terms of cases is India (42,951,556 infections and 514,589 deaths), followed by Brazil (28,978,052 infections and 651,522 deaths).
Of 19 antibodies, 17 were ineffective against the BA.2 subvariant. The researchers found that bebtelovimab, the latest monoclonal antibody to receive FDA Emergency Use Authorisation, is the only currently available antibody therapy that can adequately treat all three Omicron subvariants.
With just two days before Mahashivratri, the Odisha government has issued an important instruction regarding the celebration of the much-awaited festival dedicated to Lord Shiva.
Copyright © 2024 - Odisha Television Limited All Rights Reserved.